Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins

Journal of Controlled Release - Tập 102 - Trang 619-627 - 2005
Petra van de Wetering1, Andrew T. Metters1, Ronald G. Schoenmakers1, Jeffrey A. Hubbell1
1Institute for Biomedical Engineering, Swiss Federal Institute of Technology (ETHZ) and University of Zurich, Moussonstrasse 18; CH-8044 Zurich, Switzerland

Tài liệu tham khảo

van Dijk-Wolthuis, 1997, Degradation and release behaviour of dextran-based hydrogels, Macromolecules, 30, 4639, 10.1021/ma9704018

Kuijpers, 2000, Combined gelatin–chondroitin sulfate hydrogels for controlled release of cationic antibacterial proteins, Macromolecules, 33, 3705, 10.1021/ma9917702

Hennink, 2002, Novel crosslinking methods to design hydrogels, Adv. Drug Deliv. Rev., 54, 13, 10.1016/S0169-409X(01)00240-X

Elbert, 2001, Protein delivery from materials formed by self-selective conjugate addition reactions, J. Control. Release, 76, 11, 10.1016/S0168-3659(01)00398-4

Friedman, 1965, Relative nucleophilic reactivities of amino groups and mercaptide ions in addition reactions with α,β-unsaturated compounds, J. Am. Chem. Soc., 87, 3672, 10.1021/ja01094a025

Schoenmakers, 2004, The effect of the linker on the hydrolysis rate of drug-linked ester bonds, J. Control. Release, 95, 291, 10.1016/j.jconrel.2003.12.009

Vance, 1999, Growth hormone therapy in adults and children, New Engl. J. Med., 341, 1206, 10.1056/NEJM199910143411607

Massey, 1998, Possible therapeutic effects of growth hormone on wound healing in the diabetic patient, J. Am. Podiatr. Med. Assoc., 88, 25, 10.7547/87507315-88-1-25

Herndon, 1990, Effects of recombinant human growth hormone on donor site healing in severely burned children, Ann. Surg., 212, 424, 10.1097/00000658-199010000-00005

Clark, 1996, Long-acting growth hormones produced by conjugation with polyethylene glycol, J. Biol. Chem., 271, 21969, 10.1074/jbc.271.36.21969

Johnson, 1996, A month-long effect from a single injection of microencapsulated human growth hormone, Nat. Med., 2, 795, 10.1038/nm0796-795

Silverman, 2002, A long-acting human growth hormone (Nutropin Depot®): efficacy and safety following two years of treatment in children with growth hormone deficiency, J. Pediatr. Endocrinol. Metab., 15, 715, 10.1515/JPEM.2002.15.S2.715

Reiter, 2001, A multicenter study of the efficacy and safety of sustained-release growth hormone in the treatment of naive pediatric patients with growth hormone deficiency, J. Clin. Endocrinol. Metab., 86, 4700, 10.1210/jc.86.10.4700

Udenfriend, 1972, Fluorescamine: a reagent for assay of amino acids, peptides, and primary amines in the picomole range, Science, 178, 871, 10.1126/science.178.4063.871

Mason, 2001, Predicting controlled-release behavior of degradable PLA-b–PEG-b–PLA hydrogels, Macromolecules, 34, 4630, 10.1021/ma010025y

Lustig, 1988, Solute diffusion in swollen membranes: IX. Scaling laws for solute diffusion in gels, J. Appl. Polym. Sci., 36, 735, 10.1002/app.1988.070360401

West, 1996, Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing, Proc. Natl. Acad. Sci. U. S. A., 93, 13188, 10.1073/pnas.93.23.13188

Ingham, 1984, Protein precipitation with polyethylene glycol, Methods Enzymol., 104, 351, 10.1016/S0076-6879(84)04101-X

Cunningham, 1991, Dimerization of human growth hormone by zinc, Science, 253, 545, 10.1126/science.1907025

Kim, 1999, Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism, Biotechnol. Bioeng., 65, 659, 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9

Chantalat, 1995, The crystalstructure of wild-type growth-hormone at 2.5 Ångstrom resolution, Prot. Peptide Letters, 2, 333, 10.2174/092986650202220524124754